BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 30270816)

  • 1. Alterations in mitochondria-endoplasmic reticulum connectivity in human brain biopsies from idiopathic normal pressure hydrocephalus patients.
    Leal NS; Dentoni G; Schreiner B; Kämäräinen OP; Partanen N; Herukka SK; Koivisto AM; Hiltunen M; Rauramaa T; Leinonen V; Ankarcrona M
    Acta Neuropathol Commun; 2018 Oct; 6(1):102. PubMed ID: 30270816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathological mitochondria in neurons and perivascular astrocytic endfeet of idiopathic normal pressure hydrocephalus patients.
    Hasan-Olive MM; Enger R; Hansson HA; Nagelhus EA; Eide PK
    Fluids Barriers CNS; 2019 Dec; 16(1):39. PubMed ID: 31849332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid biomarker and brain biopsy findings in idiopathic normal pressure hydrocephalus.
    Pyykkö OT; Lumela M; Rummukainen J; Nerg O; Seppälä TT; Herukka SK; Koivisto AM; Alafuzoff I; Puli L; Savolainen S; Soininen H; Jääskeläinen JE; Hiltunen M; Zetterberg H; Leinonen V
    PLoS One; 2014; 9(3):e91974. PubMed ID: 24638077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer's disease.
    Jingami N; Asada-Utsugi M; Uemura K; Noto R; Takahashi M; Ozaki A; Kihara T; Kageyama T; Takahashi R; Shimohama S; Kinoshita A
    J Alzheimers Dis; 2015; 45(1):109-15. PubMed ID: 25428256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Cerebrospinal Fluid Beta-Amyloid and Tau in Idiopathic Normal Pressure Hydrocephalus and Neurodegenerative Dementias.
    Said HM; Kaya D; Yavuz I; Dost FS; Altun ZS; Isik AT
    Clin Interv Aging; 2022; 17():467-477. PubMed ID: 35431542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Alzheimer's Disease-Associated Risk Loci on Amyloid-β Accumulation in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
    Laiterä T; Paananen J; Helisalmi S; Sarajärvi T; Huovinen J; Laitinen M; Rauramaa T; Alafuzoff I; Remes AM; Soininen H; Haapasalo A; Jääskeläinen JE; Leinonen V; Hiltunen M
    J Alzheimers Dis; 2017; 55(3):995-1003. PubMed ID: 27802227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid Β-Peptide Increases Mitochondria-Endoplasmic Reticulum Contact Altering Mitochondrial Function and Autophagosome Formation in Alzheimer's Disease-Related Models.
    Leal NS; Dentoni G; Schreiner B; Naia L; Piras A; Graff C; Cattaneo A; Meli G; Hamasaki M; Nilsson P; Ankarcrona M
    Cells; 2020 Nov; 9(12):. PubMed ID: 33260715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.
    Leinonen V; Rauramaa T; Johansson J; Bottelbergs A; Tesseur I; van der Ark P; Pemberton D; Koivisto AM; Jääskeläinen JE; Hiltunen M; Herukka SK; Blennow K; Zetterberg H; Jokinen P; Rokka J; Helin S; Haaparanta-Solin M; Solin O; Okamura N; Kolb HC; Rinne JO
    J Alzheimers Dis; 2018; 64(1):171-179. PubMed ID: 29865068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo Characterization of Biochemical Variants of Amyloid-β in Subjects with Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease Neuropathological Change.
    Libard S; Walter J; Alafuzoff I
    J Alzheimers Dis; 2021; 80(3):1003-1012. PubMed ID: 33612546
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble amyloid precursor protein α in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus.
    Miyajima M; Nakajima M; Ogino I; Miyata H; Motoi Y; Arai H
    Eur J Neurol; 2013 Feb; 20(2):236-42. PubMed ID: 22672777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Expression of Transthyretin and Amyloid-β Protein Precursor is Altered in the Brain of Idiopathic Normal Pressure Hydrocephalus Patients.
    Laiterä T; Kurki MI; Pursiheimo JP; Zetterberg H; Helisalmi S; Rauramaa T; Alafuzoff I; Remes AM; Soininen H; Haapasalo A; Jääskeläinen JE; Hiltunen M; Leinonen V
    J Alzheimers Dis; 2015; 48(4):959-68. PubMed ID: 26444765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idiopathic normal-pressure hydrocephalus, cerebrospinal fluid biomarkers, and the cerebrospinal fluid tap test.
    Kang K; Ko PW; Jin M; Suk K; Lee HW
    J Clin Neurosci; 2014 Aug; 21(8):1398-403. PubMed ID: 24836892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased γ-secretase activity in idiopathic normal pressure hydrocephalus patients with β-amyloid pathology.
    Laiterä T; Sarajärvi T; Haapasalo A; Puli L; Kauppinen T; Mäkinen P; Rauramaa T; Tanila H; Jääskeläinen JE; Alafuzoff I; Soininen H; Leinonen V; Hiltunen M
    PLoS One; 2014; 9(4):e93717. PubMed ID: 24699723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease neuropathological change and loss of matrix/neuropil in patients with idiopathic Normal Pressure Hydrocephalus, a model of Alzheimer's disease.
    Libard S; Alafuzoff I
    Acta Neuropathol Commun; 2019 May; 7(1):98. PubMed ID: 31142354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between mini-mental state examination score, cerebrospinal fluid biomarkers, and pathology observed in brain biopsies of patients with normal-pressure hydrocephalus.
    Elobeid A; Laurell K; Cesarini KG; Alafuzoff I
    J Neuropathol Exp Neurol; 2015 May; 74(5):470-9. PubMed ID: 25868149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amyloid-β and Tau Dynamics in Human Brain Interstitial Fluid in Patients with Suspected Normal Pressure Hydrocephalus.
    Herukka SK; Rummukainen J; Ihalainen J; von Und Zu Fraunberg M; Koivisto AM; Nerg O; Puli LK; Seppälä TT; Zetterberg H; Pyykkö OT; Helisalmi S; Tanila H; Alafuzoff I; Hiltunen M; Rinne J; Soininen H; Jääskeläinen JE; Leinonen V
    J Alzheimers Dis; 2015; 46(1):261-9. PubMed ID: 25720406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. White Matter Lesions May Aid in Differentiating Idiopathic Normal Pressure Hydrocephalus and Alzheimer's Disease.
    Kuroda T; Honma M; Mori Y; Futamura A; Sugimoto A; Kasai H; Yano S; Hieda S; Kasuga K; Ikeuchi T; Ono K
    J Alzheimers Dis; 2022; 85(2):851-862. PubMed ID: 34864676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between high biomarker probability of Alzheimer's disease and improvement of clinical outcomes after shunt surgery in patients with idiopathic normal pressure hydrocephalus.
    Kazui H; Kanemoto H; Yoshiyama K; Kishima H; Suzuki Y; Sato S; Suehiro T; Azuma S; Yoshimine T; Tanaka T
    J Neurol Sci; 2016 Oct; 369():236-241. PubMed ID: 27653897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of aquaporins in the cerebrospinal fluid in patients with idiopathic normal pressure hydrocephalus.
    Hiraldo-González L; Trillo-Contreras JL; García-Miranda P; Pineda-Sánchez R; Ramírez-Lorca R; Rodrigo-Herrero S; Blanco MO; Oliver M; Bernal M; Franco-Macías E; Villadiego J; Echevarría M
    PLoS One; 2021; 16(10):e0258165. PubMed ID: 34597351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of amyloid burden differs between idiopathic normal pressure hydrocephalus and Alzheimer's disease.
    Kondo M; Tokuda T; Itsukage M; Kuriyama N; Matsushima S; Yamada K; Nakanishi H; Ishikawa M; Nakagawa M
    Neuroradiol J; 2013 Feb; 26(1):41-6. PubMed ID: 23859166
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.